Healthy Skepticism Library item: 4833

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Privitera M.
Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry.
Epilepsy Res 2006 Jan; 68:(1):52-6
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3048&uid=16377139&db=PubMed&url=http://linkinghub.elsevier.com/retrieve/pii/S0920-1211(05)00250-0

Abstract:

Different approaches to clinical trials are taken by government-sponsored (NIH, VA, MRC) and industry-sponsored clinical trials. Each sector has a different perspective and funding capacity. Sponsorship often depends on the question. Initial safety and efficacy studies for regulatory purposes usually are industry-driven. Studies of drug use as monotherapy, direct comparisons among drugs, and comparisons between categories of drugs often are more important to prescribers and payors, thereby requiring government funding. The challenge to clinician-investigators is to now find ways to fund comparison trials to determine evidence-based guidelines so patients receive the best treatment both in the short- and long-term, and the health care system gets the best value.

Keywords:
Anticonvulsants/therapeutic use* Drug Evaluation, Preclinical/economics Drug Industry/economics* Epilepsy/drug therapy* Financing, Government Humans National Institutes of Health (U.S.)/economics* Randomized Controlled Trials/economics* Randomized Controlled Trials/methods Research Support* United States